Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Benjamin Bockisch"'
Autor:
Christian Happel, Benjamin Bockisch, Britta Leonhäuser, Amir Sabet, Frank Grünwald, Daniel Groener
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Graves’ disease is one of the most common causes of hyperthyroidism. Guideline recommendations advocate the intake of thionamides for at least 1 year. If hyperthyroidism persists, subsequent radioiodine-131 treatment (RIT) is a therapeutic
Externí odkaz:
https://doaj.org/article/46522e4dad8341d0a304c1e2f561b731
Autor:
Christian Happel, Wolfgang Tilman Kranert, Benjamin Bockisch, Amir Sabet, Frank Grünwald, Daniel Groener
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Despite a significantly improved dietary iodine supply, solitary toxic thyroid nodules (STN) are still a common clinical problem in former iodine deficient areas. Radioiodine treatment (RIT) is a well-established therapeutic option with few
Externí odkaz:
https://doaj.org/article/d83e8fa652284545962d95ab4c927b15
Autor:
Justus Baumgarten, Christian Happel, Daniel Groener, Jennifer Staudt, Benjamin Bockisch, Amir Sabet, Frank Grünwald, Thomas Rink
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 4012-4019 (2022)
Aim: Therapy success in patients with differentiated thyroid cancer (DTC) after thyroidectomy and radioiodine therapy (RIT) is proven by permanent decrease in human thyroglobulin (hTg) to
Externí odkaz:
https://doaj.org/article/b4d26ed46cd748d2a5513b030eea4fd8
Autor:
Daniel Groener, Cam Tu Nguyen, Justus Baumgarten, Benjamin Bockisch, Karen Davis, Christian Happel, Nicolai Mader, Christina Nguyen Ngoc, Jennifer Wichert, Severine Banek, Philipp Mandel, Felix K. H. Chun, Nikolaos Tselis, Frank Grünwald, Amir Sabet
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Background Myelosuppression is a potential dose-limiting factor in radioligand therapy (RLT). This study aims to investigate occurrence, severity and reversibility of hematotoxic adverse events in patients undergoing RLT with 177Lu-PSMA-617
Externí odkaz:
https://doaj.org/article/8f1b086de264462294e1dd53158b7d14
Autor:
Wolfgang Tilman Kranert, Benjamin Bockisch, Jennifer Wichert, Daniel Gröner, Amir Sabet, Justus Baumgarten, Linh Quyen Christina Nguyen Ngoc, Frank Grünwald, Christian Happel
Publikováno v:
Nuklearmedizin - NuclearMedicine. 61:111-119
Zusammenfassung Ziel Ziel ist es, einen praxisorientierten Beitrag zur Diskussion eines Algorithmus zur Entlassung unter Strahlenschutzgesichtspunkten von Patienten nach Therapien mit Lu-177 markiertem PSMA zu leisten. Dieser kann als Basis zur Weite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::488538bce3e9929ed67eb352510f43ea
https://doi.org/10.1055/a-1697-8126
https://doi.org/10.1055/a-1697-8126
Autor:
Rink, Justus Baumgarten, Christian Happel, Daniel Groener, Jennifer Staudt, Benjamin Bockisch, Amir Sabet, Frank Grünwald, Thomas
Publikováno v:
Current Oncology; Volume 29; Issue 6; Pages: 4012-4019
Aim: Therapy success in patients with differentiated thyroid cancer (DTC) after thyroidectomy and radioiodine therapy (RIT) is proven by permanent decrease in human thyroglobulin (hTg) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::f54adeba70319e36c6523a306002f6ea
Autor:
Wolfgang Tilman, Kranert, Benjamin, Bockisch, Jennifer, Wichert, Daniel, Gröner, Amir, Sabet, Justus, Baumgarten, Linh Quyen Christina, Nguyen Ngoc, Frank, Grünwald, Christian, Happel
Publikováno v:
Nuklearmedizin. Nuclear medicine. 61(2)
The aim is to add a pragmatic contribution to the discussion of an algorithm to discharge patients treated with Lu-177-PSMA under the aspect of radiation protection. This also may be applied to therapies with other radioactive tracers in the future.4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3bf1eb376f9d80af293d9474372959f2
https://pubmed.ncbi.nlm.nih.gov/35170005
https://pubmed.ncbi.nlm.nih.gov/35170005
Autor:
Jennifer, Staudt, Christian, Happel, Wolfgang Tilman, Kranert, Benjamin, Bockisch, Frank, Grünwald
Publikováno v:
Nuklearmedizin. Nuclear medicine. 60(6)
ZIEL: Ziel der Untersuchung ist es, die Strahlenwirkung des βZellen der humanen Leukämie-Zelllinie BV-173 wurden mit 662keV-Photonenstrahlung respektiveBeide Strahlenarten zeigen am Auswertezeitpunkt (72h nach Versuchsbeginn fürStrahlung niedriger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a5c8ba95980419a231b219a39fdc3f2
https://pubmed.ncbi.nlm.nih.gov/34416784
https://pubmed.ncbi.nlm.nih.gov/34416784
Autor:
Daniel, Groener, Cam Tu, Nguyen, Justus, Baumgarten, Benjamin, Bockisch, Karen, Davis, Christian, Happel, Nicolai, Mader, Christina, Nguyen Ngoc, Jennifer, Wichert, Severine, Banek, Philipp, Mandel, Felix K H, Chun, Nikolaos, Tselis, Frank, Grünwald, Amir, Sabet
Publikováno v:
EJNMMI Research
Background Myelosuppression is a potential dose-limiting factor in radioligand therapy (RLT). This study aims to investigate occurrence, severity and reversibility of hematotoxic adverse events in patients undergoing RLT with 177Lu-PSMA-617 for metas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c315d7a9ad97dff3163660b905442dfa
https://pubmed.ncbi.nlm.nih.gov/34216290
https://pubmed.ncbi.nlm.nih.gov/34216290
Autor:
Britta, Leonhäuser, Christian, Happel, Daniel, Gröner, Benjamin, Bockisch, Martin, Fiebich, Dirk, Hellwig, Frank, Grünwald, Wolfgang Tilman, Kranert
Publikováno v:
Nuklearmedizin. Nuclear medicine. 58(5)
Peptide receptor radionuclide therapy (PRRT) with An algorithm was developed to determine the kidney dose using an EXCEL (Microsoft) based program. Dosimetric data were drawn and merged from three modalities: an individually calibrated gamma probe, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0d4424fb009128213fe318c9321e973b
https://pubmed.ncbi.nlm.nih.gov/31461752
https://pubmed.ncbi.nlm.nih.gov/31461752